Enhanced Oral Bioavailability of Paclitaxel Formulated in Vitamin E-TPGS Emulsified Nanoparticles of Biodegradable Polymers: In Vitro and In Vivo Studies

This publication has 32 references indexed in Scilit:

• Polymeric micelles in oral chemotherapy
  Journal of Controlled Release, 2008
• Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats
  International Journal of Pharmaceutics, 2005
• Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2
  Cancer Chemotherapy and Pharmacology, 2004
• Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin
  European Journal of Pharmaceutics and Biopharmaceutics, 2004
• Investigation of molecular interactions between paclitaxel and DPPC by langmuir film balance and differential scanning calorimetry
  Journal of Pharmaceutical Sciences, 2004
• P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel
  Cancer Chemotherapy and Pharmacology, 2002
• Oral Delivery of Taxanes
  Investigational New Drugs, 2001
• Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
  British Journal of Cancer, 2001
• Clinical pharmacology of anticancer agents in relation to formulations and administration routes
  Cancer Treatment Reviews, 1999
• Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
  Nature Medicine, 1996